Niagen Bioscience, Inc. financial data

Symbol
NAGE on Nasdaq
Location
Los Angeles, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 04 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 412% % 40%
Quick Ratio 64% % -1.5%
Debt-to-equity 41% % -37%
Return On Equity 26% % 6.8%
Return On Assets 18% % 25%
Operating Margin 13% % 62%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 80,080,488 shares 3%
Common Stock, Shares, Outstanding 79,714,000 shares 3.1%
Entity Public Float $813,900,000 USD 470%
Common Stock, Value, Issued $79,000 USD 2.6%
Weighted Average Number of Shares Outstanding, Basic 79,178,000 shares 4.3%
Weighted Average Number of Shares Outstanding, Diluted 85,436,000 shares 9.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $129,423,000 USD 30%
Cost of Revenue $46,234,000 USD 22%
Research and Development Expense $6,330,000 USD 5.2%
Selling and Marketing Expense $35,506,000 USD 20%
General and Administrative Expense $27,057,000 USD 47%
Operating Income (Loss) $16,279,000 USD 111%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $18,192,000 USD 105%
Income Tax Expense (Benefit) $810,000 USD 166%
Net Income (Loss) Attributable to Parent $17,382,000 USD 103%
Earnings Per Share, Basic 0.22 USD/shares 100%
Earnings Per Share, Diluted 0.2 USD/shares 82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $64,100,000 USD 99%
Accounts Receivable, after Allowance for Credit Loss, Current $9,741,000 USD 25%
Inventory, Net $18,791,000 USD 78%
Assets, Current $96,806,000 USD 51%
Operating Lease, Right-of-Use Asset $2,192,000 USD 27%
Intangible Assets, Net (Excluding Goodwill) $5,660,000 USD 1477%
Other Assets, Noncurrent $425,000 USD 15%
Assets $106,406,000 USD 56%
Accounts Payable, Current $10,796,000 USD 27%
Accrued Liabilities, Current $7,722,000 USD -1.2%
Liabilities, Current $19,919,000 USD 11%
Contract with Customer, Liability, Noncurrent $2,674,000 USD 3.7%
Operating Lease, Liability, Noncurrent $1,815,000 USD 9.5%
Liabilities $29,873,000 USD 35%
Retained Earnings (Accumulated Deficit) $164,528,000 USD 9.6%
Stockholders' Equity Attributable to Parent $76,533,000 USD 66%
Liabilities and Equity $106,406,000 USD 56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,883,000 USD 2572%
Net Cash Provided by (Used in) Financing Activities $3,105,000 USD
Net Cash Provided by (Used in) Investing Activities $32,000 USD 22%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 79,714,000 shares 3.1%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,956,000 USD 4465%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $64,788,000 USD 45%
Deferred Tax Assets, Valuation Allowance $40,467,000 USD -8.6%
Deferred Tax Assets, Gross $41,474,000 USD -7.2%
Operating Lease, Liability $2,817,000 USD 8.3%
Depreciation $158,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid $3,223,000 USD 11%
Operating Lease, Liability, Current $1,002,000 USD 2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $782,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,183,000 USD 4.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.077 pure 8.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $406,000 USD 48%
Lessee, Operating Lease, Liability, to be Paid, Year Three $657,000 USD 34%
Deferred Tax Assets, Operating Loss Carryforwards $34,046,000 USD -3.3%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $338,000 USD -5.3%
Operating Lease, Payments $295,000 USD 224%
Additional Paid in Capital $240,991,000 USD 5.7%
Amortization of Intangible Assets $37,000 USD -2.6%
Deferred Tax Assets, Net of Valuation Allowance $1,007,000 USD 161%